Hyperglycemia and possible mechanisms of β-cell damage in patients with COVID-19

Progressive decrease in the weight and functional reserve of β-cells is one of the main pathogenetic mechanisms of development of type 2 diabetes mellitus (DM2). The rate of progression of these processes is strictly individual, which largely determines the course of DM2 and the effectivene...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Z. A. Kalmykova, I. V. Kononenko, I. A. Sklyanik, M. V. Shestakova, N. G. Mokrysheva
Formato: article
Lenguaje:EN
RU
Publicado: Endocrinology Research Centre 2020
Materias:
Acceso en línea:https://doaj.org/article/62260d1579e642eebf8122da7935c08c
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:62260d1579e642eebf8122da7935c08c
record_format dspace
spelling oai:doaj.org-article:62260d1579e642eebf8122da7935c08c2021-11-14T09:00:23ZHyperglycemia and possible mechanisms of β-cell damage in patients with COVID-192072-03512072-037810.14341/DM12485https://doaj.org/article/62260d1579e642eebf8122da7935c08c2020-08-01T00:00:00Zhttps://www.dia-endojournals.ru/jour/article/view/12485https://doaj.org/toc/2072-0351https://doaj.org/toc/2072-0378Progressive decrease in the weight and functional reserve of β-cells is one of the main pathogenetic mechanisms of development of type 2 diabetes mellitus (DM2). The rate of progression of these processes is strictly individual, which largely determines the course of DM2 and the effectiveness of the therapy. As a rule, apoptosis and necrosis are the main mechanisms of β-cell damage and death in CD2. At the same time, recent studies allow us to consider the destruction and death of β-cells as the outcome of other types of programmed cell death (PCG), the role of innate immunity in the Genesis of CD2 IS actively discussed. This article provides an overview of the data of domestic and foreign literature of recent years regarding the molecular, intracellular characteristics of different types of β-cell PCG in CD2. The results of studies aimed at studying the possible factors and processes leading to their launch are presented.Z. A. KalmykovaI. V. KononenkoI. A. SklyanikM. V. ShestakovaN. G. MokryshevaEndocrinology Research Centrearticlecovid-19sars-cov-2stress hyperglycemiaβ-cell“cytokine storm”Nutritional diseases. Deficiency diseasesRC620-627ENRUСахарный диабет, Vol 23, Iss 3, Pp 229-234 (2020)
institution DOAJ
collection DOAJ
language EN
RU
topic covid-19
sars-cov-2
stress hyperglycemia
β-cell
“cytokine storm”
Nutritional diseases. Deficiency diseases
RC620-627
spellingShingle covid-19
sars-cov-2
stress hyperglycemia
β-cell
“cytokine storm”
Nutritional diseases. Deficiency diseases
RC620-627
Z. A. Kalmykova
I. V. Kononenko
I. A. Sklyanik
M. V. Shestakova
N. G. Mokrysheva
Hyperglycemia and possible mechanisms of β-cell damage in patients with COVID-19
description Progressive decrease in the weight and functional reserve of β-cells is one of the main pathogenetic mechanisms of development of type 2 diabetes mellitus (DM2). The rate of progression of these processes is strictly individual, which largely determines the course of DM2 and the effectiveness of the therapy. As a rule, apoptosis and necrosis are the main mechanisms of β-cell damage and death in CD2. At the same time, recent studies allow us to consider the destruction and death of β-cells as the outcome of other types of programmed cell death (PCG), the role of innate immunity in the Genesis of CD2 IS actively discussed. This article provides an overview of the data of domestic and foreign literature of recent years regarding the molecular, intracellular characteristics of different types of β-cell PCG in CD2. The results of studies aimed at studying the possible factors and processes leading to their launch are presented.
format article
author Z. A. Kalmykova
I. V. Kononenko
I. A. Sklyanik
M. V. Shestakova
N. G. Mokrysheva
author_facet Z. A. Kalmykova
I. V. Kononenko
I. A. Sklyanik
M. V. Shestakova
N. G. Mokrysheva
author_sort Z. A. Kalmykova
title Hyperglycemia and possible mechanisms of β-cell damage in patients with COVID-19
title_short Hyperglycemia and possible mechanisms of β-cell damage in patients with COVID-19
title_full Hyperglycemia and possible mechanisms of β-cell damage in patients with COVID-19
title_fullStr Hyperglycemia and possible mechanisms of β-cell damage in patients with COVID-19
title_full_unstemmed Hyperglycemia and possible mechanisms of β-cell damage in patients with COVID-19
title_sort hyperglycemia and possible mechanisms of β-cell damage in patients with covid-19
publisher Endocrinology Research Centre
publishDate 2020
url https://doaj.org/article/62260d1579e642eebf8122da7935c08c
work_keys_str_mv AT zakalmykova hyperglycemiaandpossiblemechanismsofbcelldamageinpatientswithcovid19
AT ivkononenko hyperglycemiaandpossiblemechanismsofbcelldamageinpatientswithcovid19
AT iasklyanik hyperglycemiaandpossiblemechanismsofbcelldamageinpatientswithcovid19
AT mvshestakova hyperglycemiaandpossiblemechanismsofbcelldamageinpatientswithcovid19
AT ngmokrysheva hyperglycemiaandpossiblemechanismsofbcelldamageinpatientswithcovid19
_version_ 1718429466586251264